Selectis Health, Inc.
GBCS
$3.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | 9.67M | 10.84M | 10.44M | 10.49M | 10.40M |
| Total Revenue | 9.67M | 10.84M | 10.44M | 10.49M | 10.40M |
| Cost of Revenue | 7.00M | 8.52M | 8.16M | 8.08M | 7.87M |
| Gross Profit | 2.67M | 2.32M | 2.29M | 2.41M | 2.53M |
| SG&A Expenses | 2.68M | 2.25M | 2.37M | 2.46M | 2.27M |
| Depreciation & Amortization | 384.00K | 364.70K | 362.70K | 363.00K | 362.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.07M | 11.14M | 10.89M | 10.91M | 10.50M |
| Operating Income | -395.70K | -297.00K | -450.30K | -421.70K | -97.30K |
| Income Before Tax | -803.30K | 752.40K | -308.00K | -656.00K | -576.50K |
| Income Tax Expenses | 800.00 | -- | -- | -- | -- |
| Earnings from Continuing Operations | -804.10K | 752.40K | -308.00K | -656.00K | -576.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -804.10K | 752.40K | -308.00K | -656.00K | -576.50K |
| EBIT | -395.70K | -297.00K | -450.30K | -421.70K | -97.30K |
| EBITDA | -11.70K | 67.70K | -87.50K | -58.70K | 265.50K |
| EPS Basic | -0.26 | 0.24 | -0.10 | -0.22 | -0.19 |
| Normalized Basic EPS | -0.15 | 0.02 | -0.13 | -0.13 | -0.14 |
| EPS Diluted | -0.26 | 0.24 | -0.10 | -0.22 | -0.20 |
| Normalized Diluted EPS | -0.15 | 0.02 | -0.13 | -0.13 | -0.14 |
| Average Basic Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.07M |
| Average Diluted Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.12% | -- | -- | -- | -- |